1. Biologicals to direct nanotherapeutics towards HER2-positive breast cancers
   Gautam Kumar et al, 2020, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
2. Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells
   Majid Momeny et al, 2017, Scientific Reports CrossRef
3. Immunotherapeutic Approaches in Ovarian Cancer
   Hyunho Yoon et al, 2023, Current Issues in Molecular Biology CrossRef
4. Homodimer 99mTc-HYNIC-E(SSSLTVPWY)2 peptide improved HER2-overexpressed tumor targeting and imaging
   Fatemeh Ebrahimi et al, 2022, Medical Oncology CrossRef